Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes
1 other identifier
observational
80,000
1 country
1
Brief Summary
To evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 3, 2015
CompletedFirst Posted
Study publicly available on registry
September 7, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedSeptember 7, 2015
September 1, 2015
2 months
September 3, 2015
September 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
First occurrence of cardiovascular disease
First recorded diagnosis of cardiovascular disease during follow-up: stable angina, unstable angina, myocardial infarction, unheralded coronary death, heart failure, transient ischaemic attack, ischaemic stroke, subarachnoid haemorrhage, intracerebral haemorrhage, peripheral arterial disease, abdominal aortic aneurysm, ventricular arrhythmia, cardiac arrest, or sudden cardiac death
10 years
Secondary Outcomes (2)
Cardiovascular mortality
10 years
All cause mortality
10 years
Interventions
This study is based on the analysis of linked electronic health records (CALIBER dataset)
Eligibility Criteria
Patients in the CALIBER database who have diabetes, are included in the Clinical Practice Research Datalink (CPRD) and consented to data linkage.
You may qualify if:
- Patients with diabetes at or before study entry, and participants who develop new-onset diabetes during follow-up.
- Age ≥ 18 years
- Data collected in the period 1997-2010
- Minimum time since registration of 1 year
- Minimum of 1 year of up to standard data (CPRD quality standard)
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The George Institute for Global Health, Nuffield Department for Population Health, University of Oxford
Oxford, Oxford, OX1 3BD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sanne Peters
The George Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2015
First Posted
September 7, 2015
Study Start
August 1, 2015
Primary Completion
October 1, 2015
Study Completion
November 1, 2016
Last Updated
September 7, 2015
Record last verified: 2015-09